$12.75
+1.27 (+11.06%)
Open$11.49
Previous Close$11.48
Day High$12.75
Day Low$11.49
52W High$18.20
52W Low$2.88
Volume—
Avg Volume47.9K
Market Cap23.92M
P/E Ratio—
EPS$-5.64
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 10.61M | 10.68M | 9.55M |
| Net Income | 789.2K | 807.9K | 770.6K |
| Profit Margin | 7.4% | 7.6% | 8.1% |
| EBITDA | 1.40M | 1.47M | 1.23M |
| Free Cash Flow | 547.8K | 770.2K | 737.4K |
| Rev Growth | -2.0% | +19.5% | +10.5% |
| Debt/Equity | 0.36 | 0.38 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |